Regulation2 min read

Maryland Shields Vets Prescribing Cannabis for Pets in Industry First

Maryland becomes first state to protect veterinarians recommending medical cannabis for animals, opening new revenue channel for cannabis companies.

April 15, 2026 at 1:30 PMCannabismarketcap

Maryland breaks new ground in cannabis regulation by enacting legislation that protects veterinarians who recommend medical marijuana for animals. The bills create legal safeguards for veterinary professionals discussing cannabis treatments with pet owners, marking the first state-level framework specifically addressing veterinary cannabis recommendations.

The veterinary cannabis market represents an untapped revenue stream for licensed operators, with pet owners increasingly seeking alternative treatments for conditions like epilepsy, chronic pain, and anxiety in animals. Industry estimates suggest the pet CBD market alone reached $400 million in 2023, though most products exist in regulatory gray areas without veterinary oversight.

Maryland's approach addresses a critical barrier that has prevented veterinarians from engaging with cannabis treatments. Previously, vets faced potential disciplinary action for discussing cannabis options, even in states with robust medical marijuana programs. This regulatory gap forced pet owners to navigate cannabis treatments without professional veterinary guidance, limiting market growth and product standardization.

The legislation positions Maryland's licensed cannabis operators to develop veterinary-specific product lines and establish relationships with veterinary practices. Companies with established medical cannabis operations can leverage existing cultivation and manufacturing infrastructure to serve this emerging market segment, potentially commanding premium pricing for veterinary-grade products.

This regulatory development signals broader acceptance of cannabis in medical applications beyond human use. Other states with mature cannabis programs will likely monitor Maryland's implementation, particularly regarding product testing standards, dosing protocols, and veterinary training requirements. The precedent could accelerate similar legislation nationwide, creating a new vertical within the cannabis industry that bypasses traditional recreational and medical human-use categories.